158 related articles for article (PubMed ID: 28348076)
1. The crystal structure of a multidomain protease inhibitor (HAI-1) reveals the mechanism of its auto-inhibition.
Liu M; Yuan C; Jensen JK; Zhao B; Jiang Y; Jiang L; Huang M
J Biol Chem; 2017 May; 292(20):8412-8423. PubMed ID: 28348076
[TBL] [Abstract][Full Text] [Related]
2. Crystal Structure of a Two-domain Fragment of Hepatocyte Growth Factor Activator Inhibitor-1: FUNCTIONAL INTERACTIONS BETWEEN THE KUNITZ-TYPE INHIBITOR DOMAIN-1 AND THE NEIGHBORING POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN.
Hong Z; De Meulemeester L; Jacobi A; Pedersen JS; Morth JP; Andreasen PA; Jensen JK
J Biol Chem; 2016 Jul; 291(27):14340-14355. PubMed ID: 27189939
[TBL] [Abstract][Full Text] [Related]
3. Recombinant hepatocyte growth factor activator inhibitor 1: expression in Drosophila S2 cells, purification and crystallization.
Liu M; Yuan C; Jiang Y; Jiang L; Huang M
Acta Crystallogr F Struct Biol Commun; 2017 Jan; 73(Pt 1):45-50. PubMed ID: 28045393
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-7 induces homotypic tumor cell aggregation via proteolytic cleavage of the membrane-bound Kunitz-type inhibitor HAI-1.
Ishikawa T; Kimura Y; Hirano H; Higashi S
J Biol Chem; 2017 Dec; 292(50):20769-20784. PubMed ID: 29046355
[TBL] [Abstract][Full Text] [Related]
5. The solution structure of the MANEC-type domain from hepatocyte growth factor activator inhibitor-1 reveals an unexpected PAN/apple domain-type fold.
Hong Z; Nowakowski M; Spronk C; Petersen SV; Andreasen PA; Koźmiński W; Mulder FA; Jensen JK
Biochem J; 2015 Mar; 466(2):299-309. PubMed ID: 25510835
[TBL] [Abstract][Full Text] [Related]
6. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1.
Kirchhofer D; Peek M; Li W; Stamos J; Eigenbrot C; Kadkhodayan S; Elliott JM; Corpuz RT; Lazarus RA; Moran P
J Biol Chem; 2003 Sep; 278(38):36341-9. PubMed ID: 12815039
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of matriptase in complex with its inhibitor hepatocyte growth factor activator inhibitor-1.
Zhao B; Yuan C; Li R; Qu D; Huang M; Ngo JC
J Biol Chem; 2013 Apr; 288(16):11155-64. PubMed ID: 23443661
[TBL] [Abstract][Full Text] [Related]
8. TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.
Hashimoto T; Kato M; Shimomura T; Kitamura N
FEBS J; 2010 Dec; 277(23):4888-900. PubMed ID: 20977675
[TBL] [Abstract][Full Text] [Related]
9. Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein.
Mitchell AC; Kannan D; Hunter SA; Parra Sperberg RA; Chang CH; Cochran JR
J Biol Chem; 2018 Apr; 293(14):4969-4980. PubMed ID: 29386351
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1.
Denda K; Shimomura T; Kawaguchi T; Miyazawa K; Kitamura N
J Biol Chem; 2002 Apr; 277(16):14053-9. PubMed ID: 11805118
[TBL] [Abstract][Full Text] [Related]
11. Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase.
Kojima K; Tsuzuki S; Fushiki T; Inouye K
J Biol Chem; 2008 Feb; 283(5):2478-87. PubMed ID: 18048349
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor activator (HGFA): molecular structure and interactions with HGFA inhibitor-1 (HAI-1).
Eigenbrot C; Ganesan R; Kirchhofer D
FEBS J; 2010 May; 277(10):2215-22. PubMed ID: 20402765
[TBL] [Abstract][Full Text] [Related]
13. Roles of Kunitz domains in the anti-invasive effect of hepatocyte growth factor activator inhibitor type 1 in human glioblastoma cells.
Miyata S; Fukushima T; Kohama K; Tanaka H; Takeshima H; Kataoka H
Hum Cell; 2007 Nov; 20(4):100-6. PubMed ID: 17949349
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of an active zymogen protease: the zymogen form of matriptase is regulated by HAI-1 and HAI-2.
Skovbjerg S; Holt-Danborg L; Nonboe AW; Hong Z; Frost ÁK; Schar CR; Thomas CC; Vitved L; Jensen JK; Vogel LK
Biochem J; 2020 May; 477(9):1779-1794. PubMed ID: 32338287
[TBL] [Abstract][Full Text] [Related]
15. Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin.
Fan B; Wu TD; Li W; Kirchhofer D
J Biol Chem; 2005 Oct; 280(41):34513-20. PubMed ID: 16103126
[TBL] [Abstract][Full Text] [Related]
16. Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B.
Shia S; Stamos J; Kirchhofer D; Fan B; Wu J; Corpuz RT; Santell L; Lazarus RA; Eigenbrot C
J Mol Biol; 2005 Mar; 346(5):1335-49. PubMed ID: 15713485
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease.
Kato M; Hashimoto T; Shimomura T; Kataoka H; Ohi H; Kitamura N
J Biochem; 2012 Feb; 151(2):179-87. PubMed ID: 22023801
[TBL] [Abstract][Full Text] [Related]
18. Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form.
Shimomura T; Denda K; Kawaguchi T; Matsumoto K; Miyazawa K; Kitamura N
J Biochem; 1999 Nov; 126(5):821-8. PubMed ID: 10544273
[TBL] [Abstract][Full Text] [Related]
19. Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor.
Kawaguchi T; Qin L; Shimomura T; Kondo J; Matsumoto K; Denda K; Kitamura N
J Biol Chem; 1997 Oct; 272(44):27558-64. PubMed ID: 9346890
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor activator inhibitor type‑1 in cancer: advances and perspectives (Review).
Zheng Q; Wu H; Cao J; Ye J
Mol Med Rep; 2014 Dec; 10(6):2779-85. PubMed ID: 25310042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
